Nanomedicine CDMO Case Highlights

Manufacturing case – Cenyx Biotech, Inc.
Cenyx Biotech, Inc. is developing a SAH (Subarachnoid Hemorrhage)
and MIS (Malignant Ischemic Stroke) treatment using nanomedicine.
This ceria-cored nanomedicine is developed with INNOSUFRACE
platform technology and has both therapeutic function and
biocompatibility. Our experience covers the entire cycle
from R&D to manufacturing for nonclinical studies

Surface chemistry modification

Surface antibody conjugation in

developing CAR-T cell, polymer

coating modification to improve

biocompatibility of various

nanomedicines

Drug Delivery System

Development of Theragnostics

drug using iron oxide embedded

silica nanoparticle, modification

of pore dimensions for

multifunctional drug delivery

Photothermal/Diagnostics

Concentrating large

amount of gold nanoparticles

with DDS carrier, novel metal

coatings for SERS